Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,846
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
for
Multiple Sclerosis Spasticity
Location: Foxborough MA, Levis, Montreal, Philadelphia PA, Ottawa,
Sponsor: Celgene
Sex: All
Age: 18 - 70
Code: NCT06782490
Phase2, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: St. John's, Westbrook ME, Boston MA, Quebec, Sherbrooke,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase3, Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Location: New York NY, Clifton Park NY, Orlando FL, Toronto,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06858319
Phase3, Recruiting
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
for
Multiple Myeloma
Location: New York NY, Charlottesville VA, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07073547
Phase1, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
for
Tibial Fractures, Pain
Location: Cambridge MA, Baltimore MD, Falls Church VA,
Sponsor: Major Extremity Trauma Research Consortium
Sex: All
Age: 18 - 70+
Code: NCT07006675
Phase3, Recruiting
Seminar in Unwavering Empowering Presence Optimized for Rehabilitation Teams
for
Communication
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT07071116
Recruiting
Study in Advanced Solid Tumor Patients
for
Advanced Solid Tumor
Location: Nashville TN, Houston TX, San Antonio TX,
Sponsor: Callio Therapeutics
Sex: All
Age: 18+
Code: NCT07300943
Phase1, Phase2, Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
for
Agitation, Alzheimer Disease
Location: Foxborough MA, Manhasset NY, Toms River NJ,
Sponsor: Celgene
Sex: All
Age: 55 - 70+
Code: NCT06808984
Phase2, Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase2, Phase3, Recruiting
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: New Hyde Park NY, Long Island City NY, New York NY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07018323
Phase2, Recruiting
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
for
Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR),
Location: Westbrook ME, Toronto, Indianapolis IN, Nashville TN,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07403721
Phase1, Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
for
Heart Failure
Location: Quebec, Winchester, Ottawa, Camp Hill PA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 40 - 70+
Code: NCT06979362
Phase2, Recruiting
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
for
Ovarian Cancer
Location: Philadelphia PA, Nashville TN, Peoria IL, St Louis MO,
Sponsor: Nerviano Medical Sciences
Sex: Female
Age: 18+
Code: NCT06930755
Phase1, Recruiting
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
for
Renal Cell Carcinoma
Location: Mineola NY, New York NY, Durham NC, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07049926
Phase1, Phase2, Recruiting
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
for
Locally Advanced/Metastatic Solid Tumors
Location: New Haven CT, Indianapolis IN, Nashville TN, Denver CO,
Sponsor: InSilico Medicine Hong Kong Limited
Sex: All
Age: 18+
Code: NCT06414460
Phase1, Phase2, Recruiting
Quality of Life in Presbyopic Patients Who Are Treated With Qlosi
for
Presbyopia, Glasses, Dry Eye
Location: Memphis TN, Medina MN
Sponsor: Southern College of Optometry
Sex: All
Age: 45 - 64
Code: NCT07113210
Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
for
Pulmonary Disease, Chronic Obstructive
Location: Bangor ME, Fall River MA, Mount Kisco NY,